Tags:DrugFastFoodFoodTechGrowthProductTechnology
Developed a new class of therapies to target and selectively destroy tumor cells
Total raised: $21M

Investors 3

Funding Rounds 5

DateSeriesAmountInvestorsDeal News
02.04.2019Series D$40M-Aura Biosc...
21.12.2017Series C$30MArix Biosc...Arix Biosc...
29.09.2016-$8M-Aura Biosc...
05.03.2015Series B$21M-Aura Biosc...
15.08.2014-$4M-Aura Biosc...

Mentions in press and media 9

DateTitleDescriptionCategoryAuthorSource
02.04.2019Aura Biosc...Aura Biosciences, a Cambridge,...USA-finsmes.co...
02.04.2019Daily fund...DynamiCare raised $4.1M; OnSca...-Kristin Ka...vator.tv/n...
21.12.2017Aura Biosc...Aura Biosciences, a Cambridge,...USA-finsmes.co...
21.12.2017Arix Biosc...---arixbiosci...
29.09.2016Aura Biosc...Aura Biosciences, a Cambridge,...USA-finsmes.co...
05.03.2015Aura Biosc...“Our investors share our vis...--medcitynew...
05.03.2015Aura Biosc...Aura Biosciences, a Cambridge,...USA-finsmes.co...
15.08.2014Aura Biosc...Aura has slowly and steadily b...--medcitynew...
28.12.2012Nanotrepre...It was developed in partnershi...--medcitynew...